Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Cardiomyopathies, Primary

methoxyhydroxyphenylglycol has been researched along with Cardiomyopathies, Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatnager, M; DeCaro, M; Dombrowski, K; Huynh, TT; Khoury, J; Lai, EW; Moussouttas, M; Pacak, K1
Carmona, G; DeCaro, M; Dombrowski, K; Huynh, TT; Khoury, J; Lai, EW; Moussouttas, M; Pacak, K1

Other Studies

2 other study(ies) available for methoxyhydroxyphenylglycol and Cardiomyopathies, Primary

ArticleYear
Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage.
    Acta neurochirurgica, 2013, Volume: 155, Issue:8

    Topics: Adult; Aged; Biomarkers; Cardiomyopathies; Catecholamines; Female; Humans; Intracranial Aneurysm; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Risk Factors; Subarachnoid Hemorrhage; Thromboembolism; Ventriculostomy

2013
CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.
    Neurocritical care, 2011, Volume: 14, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cardiomyopathies; Catecholamines; Dihydroxyphenylalanine; Dopamine; Echocardiography; Epinephrine; Female; Heart; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Subarachnoid Hemorrhage; Sympathetic Nervous System; Tomography, X-Ray Computed; Ventriculostomy

2011